Exact Insights Logo

Novavax, Inc. logo

novavax.com

21 Firstfield Road, Gaithersburg, 20878, US

Novavax, Inc.

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Novavax, Inc. logo

Novavax, Inc.

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

novavax.com

21 Firstfield Road, Gaithersburg, 20878, US

Details

Year founded

1987

Revenue

1B-10B

Employees

1001-5000

Number of locations

4

NAICS

541714

SIC

2834

Products & Services

Outlines the company's specialized services and operational strengths.

  • Biopharmaceuticals
  • COVID-19 Vaccine
  • Design and Development Services
  • Contact us in order to access

Equipment

Provides a detailed list of machinery and tools utilized on the company's premises.

No relevant data to display at this point in time

Ramping up production

Indicates the company's current production trend and growth trajectory.

TRUE

Our production algorithm is showing that novavax is ramping up production.

Target industries

Medical
Biotechnology

Employees working in Novavax, Inc.

Purnell Gaither

Owner

Janel Lopez

Managing director

Filip Dubovsky

President research and development

Jim Kelly

Executive vice president and chief financial officer

Johnny Nunez

Service management process owner

Employees working in Novavax, Inc.

Purnell Gaither

Owner

Janel Lopez

Managing director

Filip Dubovsky

President research and development

Jim Kelly

Executive vice president and chief financial officer

Johnny Nunez

Service management process owner

Henrietta Ukwu

Executive vice president and chief regulatory officer

Elaine O'hara

Chief strategy officer

News

Investor's Business Daily

Is Novavax Stock A Buy After Pulling Back From A Sanofi-Tied High?

MarketWatch

Novavax Inc. stock outperforms competitors on strong trading day

Nasdaq

Decoding Novavax's Options Activity: What's the Big Picture?

Investor's Business Daily

Is Novavax Stock A Buy After Pulling Back From A Sanofi-Tied High?

Novavax stock remains volatile. Shares hit a nearly two-year high at 23.86 on June 6, but closed down almost 7%, after Novavax said in a Securities and Exchange...

MarketWatch

Novavax Inc. stock outperforms competitors on strong trading day

Nasdaq

Decoding Novavax's Options Activity: What's the Big Picture?

MarketWatch

Novavax Inc. stock outperforms competitors on strong trading day

Nasdaq

Decoding Novavax's Options Activity: What's the Big Picture?

MarketBeat

Susquehanna Fundamental Investments LLC Invests $1.50 Million in Novavax, Inc. (NASDAQ:NVAX)

Book a demo

Locations (4)

HQ

Novavax, Inc.

21 Firstfield Road, Gaithersburg, 20878, US

Novavax, Inc.

Fraumünsterstrasse 16, 8001 Zurich, CH

Novavax, Inc.

Líbalova 2348/1 Chodov, Praha 149 00, CZ

Novavax, Inc.

Kungsgatan 109 Uppsala, Uppsala County SE-753 18, SE

Frequently Asked Questions


Novavax, Inc. offers a range of services and capabilities, including Biopharmaceuticals.


Get the full services & capabilities list of Novavax, Inc.

Novavax, Inc. serves several industries, including the medical industry.


Get the full target industries list of Novavax, Inc.

Novavax, Inc. operates from 4 locations.


Get a free locations and target markets review for Novavax, Inc.

Novavax, Inc.'s revenue is $1.6B.


Get a free financial data review of Novavax, Inc.

The headquarters of Novavax, Inc. are located in 21 firstfield road, gaithersburg, maryland 20878, united states.


Get a free locations and target markets review for Novavax, Inc.

The NAICS code for Novavax, Inc. is 541714.


Get a free business data review for Novavax, Inc.

Novavax, Inc. has 1992 employees.


Get a free workforce data review of Novavax, Inc.

The official website of Novavax, Inc. is https://www.novavax.com.


Novavax, Inc. was founded in 1987.